Home > Protocol Summaries: Compounds > denagliptin

Protocol Summaries: denagliptin

Protocol Summaries for denagliptin
GSK
Study ID		 Phase Title Status
DPB100925 Phase 2 See Detailed Description Completed
DPB106652 phase 2 Clinical Evaluation of GW823093C in Patients with Type 2 Diabetes Mellitus -Double-Blind Dose Finding and the Extension Study- <Phase 2 study> Terminated
DPB106653 Phase 2 PK/PD study of GW823093 in Japanese subjects with T2DM A single-blind, placebo controlled, randomized, multi-dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GW823093C administered orally for 7 days in Japanese subjects with type 2 diabetes Completed
DPB107246 Phase 3 A multi-center, double-blind, parallel-group, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of denagliptin in subjects with type 2 diabetes mellitus Suspended

Filter list by: